Tarsus Pharmaceuticals, Inc. — All Filings
607 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | 424B5 | 0001193125-22-139056 | May 4, 2022 | — |
| FWP | FWP | 0001193125-22-137505 | May 3, 2022 | — |
| 8-K | 8-K | 0001193125-22-137573 | May 3, 2022 | May 2, 2022 |
| DEFA14A | DEFA14A | 0001193125-22-135228 | May 2, 2022 | — |
| 424B5 | 424B5 | 0001193125-22-135344 | May 2, 2022 | — |
| 8-K | 8-K | 0001193125-22-135403 | May 2, 2022 | — |
| DEF 14A | DEF 14A | 0001193125-22-135208 | May 2, 2022 | Jun 16, 2022 |
| 8-K | 8-K | 0001193125-22-135307 | May 2, 2022 | — |
| S-8 | S-8 | 0001819790-22-000012 | Mar 14, 2022 | — |
| 10-K | 10-K | 0001819790-22-000010 | Mar 14, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0001819790-22-000009 | Mar 14, 2022 | — |
| 4 | FORM 4 | 0001827672-22-000002 | Mar 11, 2022 | Mar 9, 2022 |
| 4 | FORM 4 | 0001827564-22-000002 | Mar 11, 2022 | Mar 9, 2022 |
| 4 | FORM 4 | 0001839516-22-000002 | Mar 11, 2022 | Mar 9, 2022 |
| 4 | FORM 4 | 0001519692-22-000002 | Mar 11, 2022 | Mar 9, 2022 |
| 4 | FORM 4 | 0001841401-22-000002 | Mar 11, 2022 | Mar 9, 2022 |
| 4 | FORM 4 | 0001788542-22-000002 | Mar 11, 2022 | Mar 9, 2022 |
| 4 | FORM 4 | 0001827584-22-000002 | Mar 11, 2022 | Mar 9, 2022 |
| SC 13G/A | — | 0000929638-22-000471 | Feb 14, 2022 | — |
| SC 13G/A | TARSUS PHARMACEUTICALS, INC. | 0000902664-22-001587 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-042273 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-041990 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-041979 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-22-007082 | Feb 11, 2022 | — |
| 3 | FORM 3 | 0001661539-22-000004 | Feb 3, 2022 | Feb 1, 2022 |
| 4 | FORM 4 | 0001661539-22-000005 | Feb 3, 2022 | Feb 1, 2022 |
| 8-K | 8-K | 0001819790-22-000004 | Feb 2, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-021382 | Jan 28, 2022 | — |
| 8-K | 8-K | 0001819790-22-000002 | Jan 4, 2022 | Dec 31, 2021 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-001241 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-001245 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001819790-21-000057 | Dec 3, 2021 | Dec 1, 2021 |
| 4 | FORM 4 | 0001819790-21-000059 | Dec 3, 2021 | Dec 1, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-064905 | Nov 16, 2021 | Nov 11, 2021 |
| 4 | FORM 4 | 0001819790-21-000055 | Nov 10, 2021 | Nov 8, 2021 |
| 10-Q | 10-Q | 0001819790-21-000053 | Nov 10, 2021 | Sep 30, 2021 |
| 8-K | 8-K | 0001819790-21-000050 | Nov 9, 2021 | — |
| 4 | FORM 4 | 0001819790-21-000047 | Nov 8, 2021 | Nov 4, 2021 |
| EFFECT | — | 9999999995-21-004231 | Nov 5, 2021 | — |
| 4 | FORM 4 | 0001819790-21-000045 | Nov 4, 2021 | Nov 2, 2021 |
| UPLOAD | — | 0000000000-21-013353 | Nov 3, 2021 | — |
| CORRESP | — | 0001193125-21-318381 | Nov 3, 2021 | — |
| 4 | FORM 4 | 0001819790-21-000041 | Nov 3, 2021 | Nov 1, 2021 |
| 4 | FORM 4 | 0001819790-21-000043 | Nov 3, 2021 | Nov 1, 2021 |
| 8-K | 8-K | 0001193125-21-315651 | Nov 1, 2021 | — |
| S-3 | S-3 | 0001193125-21-315579 | Nov 1, 2021 | — |
| 4 | FORM 4 | 0001819790-21-000039 | Oct 14, 2021 | Oct 12, 2021 |
| 4 | FORM 4 | 0001819790-21-000037 | Oct 14, 2021 | Oct 12, 2021 |
| 4 | FORM 4 | 0001819790-21-000035 | Oct 12, 2021 | Oct 8, 2021 |
| 4 | FORM 4 | 0001819790-21-000033 | Oct 12, 2021 | Oct 8, 2021 |